4.09
Prime Medicine Inc stock is traded at $4.09, with a volume of 1.87M.
It is down -2.85% in the last 24 hours and up +69.01% over the past month.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
See More
Previous Close:
$4.21
Open:
$4.22
24h Volume:
1.87M
Relative Volume:
0.55
Market Cap:
$550.09M
Revenue:
-
Net Income/Loss:
$-217.44M
P/E Ratio:
-1.8848
EPS:
-2.17
Net Cash Flow:
$-205.20M
1W Performance:
-10.50%
1M Performance:
+69.01%
6M Performance:
+44.52%
1Y Performance:
-27.09%
Prime Medicine Inc Stock (PRME) Company Profile
Name
Prime Medicine Inc
Sector
Industry
Phone
617-465-0013
Address
60 FIRST ST., CAMBRIDGE
Compare PRME with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PRME
Prime Medicine Inc
|
4.09 | 566.23M | 0 | -217.44M | -205.20M | -2.17 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-27-25 | Downgrade | Citigroup | Buy → Neutral |
May-20-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
May-20-25 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-10-24 | Initiated | JMP Securities | Mkt Outperform |
May-20-24 | Initiated | H.C. Wainwright | Buy |
May-16-24 | Upgrade | Citigroup | Neutral → Buy |
Apr-22-24 | Initiated | Chardan Capital Markets | Buy |
Apr-08-24 | Initiated | TD Cowen | Buy |
Apr-03-24 | Initiated | Wedbush | Outperform |
Jan-16-24 | Downgrade | Stifel | Buy → Hold |
Dec-08-23 | Initiated | Citigroup | Neutral |
Oct-09-23 | Initiated | BMO Capital Markets | Outperform |
Jul-31-23 | Initiated | Guggenheim | Buy |
Apr-18-23 | Initiated | Stifel | Buy |
Nov-14-22 | Initiated | Goldman | Neutral |
Nov-14-22 | Initiated | JP Morgan | Overweight |
Nov-14-22 | Initiated | Jefferies | Buy |
Nov-14-22 | Initiated | Morgan Stanley | Equal-Weight |
View All
Prime Medicine Inc Stock (PRME) Latest News
Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid strategic shift - Investing.com
Intraday Charts Show Spike in Prime Medicine Inc. ActivityShort Term High Yield Stock Tips for Active Traders - metal.it
What are the technical indicators suggesting about Prime Medicine Inc.Free Stock Trend Scanner That Work - jammulinksnews.com
What is Prime Medicine Inc. company’s growth strategyConsistent double returns - jammulinksnews.com
When is Prime Medicine Inc. stock expected to show significant growthBreakthrough investment results - jammulinksnews.com
What are Prime Medicine Inc. company’s key revenue driversHigh-impact stock picks - jammulinksnews.com
What is the risk reward ratio of investing in Prime Medicine Inc. stockOutperformance with explosive growth - jammulinksnews.com
What institutional investors are buying Prime Medicine Inc. stockAchieve consistent profits with smart trading - jammulinksnews.com
Does Prime Medicine Inc. stock perform well during market downturnsExplosive earnings growth - jammulinksnews.com
What are the latest earnings results for Prime Medicine Inc.Get high-impact stock recommendations now - jammulinksnews.com
What makes Prime Medicine Inc. stock price move sharplyFree Real-Time Trading Opportunities - metal.it
How Prime Medicine Inc. stock performs during market volatilitySmart Return Focused Trading - metal.it
What drives Prime Medicine Inc. stock priceUnmatched market performance - PrintWeekIndia
Is Prime Medicine Inc. a good long term investmentFree Capital Growth Strategies - Autocar Professional
Is Prime Medicine Inc. stock a good hedge against inflationFree Risk Assessment Services - jammulinksnews.com
What analysts say about Prime Medicine Inc. stockAccelerated investment success - Autocar Professional
Prime Medicine Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com
Prime Medicine(PRME) Shares Soar 10.65% on Analyst Rating, Funding Boost - AInvest
Prime Medicine Surges 18% on Funding Catalyst: Is This the Start of a Biotech Breakout? - AInvest
BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT - MSN
Prime Medicine stock price target reiterated at $6 by JMP on CF funding - Investing.com Canada
Prime Medicine (PRME.O) Surges 5.9%: What’s Behind the Intraday Rally? - AInvest
Prime Medicine (PRME): A High-Conviction Biotech Play with a 154% Upside - AInvest
10 Hot Penny Stocks to Invest in Now - Insider Monkey
Prime Medicine Inc Stock (PRME) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):